« Back
Home /
Trelagliptin succinate

Trelagliptin succinate

Item no.	M8882-50mg
Manufacturer	AbMole
CASRN	1029877-94-8
Amount	50mg
Specific against	other
Purity	>99.0%
Alias	SYR472 succinate
Available
Target Information	Dipeptidyl Peptidase
Molecular Weight	475, 47
Solubility	DMSO 90 mg/mL; Water 90 mg/mL
Bioactivity information	Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Delivery expected until 10/4/2024

Express Delivery: Save 9 days

Compare

Add to wishlist

Recommend by mail